Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Brazil to make PrEP available to populations at highest risk of HIV infection

Brazil will make the HIV preventative drug, PrEP (pre-exposure prophylaxis), available to populations at highest risk of HIV infection. This includes sex workers, mixed HIV-status couples, transgender people and gay and bisexual men.

Published
26 May 2017
From
Gay Star News
Facing our fears: What does news of a possible PrEP failure mean?

In light of recent reports of a person becoming HIV positive while using PrEP, our community’s collective response can inform the future of HIV prevention and sexual health promotion in Australia. While HIV/AIDS organisations and community groups are leading the way to allay public concerns, we address some of the questions surrounding this unusual event.

Published
26 May 2017
From
Emen8
Ramadan, Fasting & HIV

Ramadan is the name of one of the 12 lunar months of the Islamic calendar. For 29 days of Ramadan, Muslims fast from sunrise until sunset. Many HIV-positive wish to join their community in observing this important month, can they?

Published
26 May 2017
From
LASS
PrEP 17 – The coming of age of PrEP

PrEP17 explores the stories of over a dozen PrEP activists; current and former PrEP users; clinicians; and policy-makers. The 36 minute documentary film, commissioned by PrEPster, shines a light on how PrEP has become available to thousands of people, despite the failures of the health system.

Published
26 May 2017
From
Prepster
Genetic test for anal cancer could identify those at high risk

A new test, based on a patient's epigenetics, could be an accurate and inexpensive way to find and treat those at highest risk of anal cancer -- a disease with growing incidence in women, men who have sex with men (MSM) and people with HIV.

Published
26 May 2017
From
Eurekalert Inf Dis
The Truth About HIV

Dr Chris van Tulleken explores the latest science around HIV, meeting health professionals, scientists, and individuals affected by it in the UK and South Africa.

Published
26 May 2017
From
BBC iPlayer (UK only, available until 24 June)
HIV 'fingerprint' tool could greatly assist vaccine development

A method that quickly fingerprints the shield of sugar molecules that helps HIV evade immune system antibodies could be very useful to vaccine developers.

Published
26 May 2017
From
HIV / AIDS News From Medical News Today
Heroin combined with fentanyl is driving overdose crisis in US

New sources of heroin and increasing adulteration with fentanyl and other stronger analogues are contributing to a growing epidemic of opioid overdose deaths in several regions of

Published
24 May 2017
By
Liz Highleyman
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that its HIV vaccine, PENNVAX®-GP, produced amongst the highest overall levels of immune response rates (cellular and humoral) ever demonstrated in a human study by an HIV vaccine.

Published
24 May 2017
From
Inovio press release
Indonesian buyers club helps people obtain generic hepatitis C treatment

A community-led buyers club in Indonesia has helped more than 100 people get generic direct-acting antiviral (DAA) drugs to treat hepatitis C and is seeing a high

Published
24 May 2017
By
Liz Highleyman
← First12345...2265Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.